Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.